Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer: A Model for Europe and Australia

Author： Lindgren P.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.2, 2002-02, pp. : 101-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer

By Benedict Ágnes Brown Ruth E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1789-1801

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of Oral Clodronate Compared with Oral Ibandronate, Intravenous Zoledronate or Intravenous Pamidronate in Breast Cancer Patients

By Paterson A McCloskey E Redzepovic J Ott I Gust R

The Journal of International Medical Research, Vol. 36, Iss. 3, 2008-05 ,pp. : 400-413

Field House Publishing

Access to resources Recommend Favorite

Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer

By Lønning Per Eystein Geisler Jürgen

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Fulvestrant as EFECTive as exemestane in advanced breast cancer

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Exemestane and aromatase inhibitors in the management of advanced breast cancer

By Dixon J Michael

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 307-316

Informa Healthcare

Access to resources Recommend Favorite